G9132
Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)
- Effective Date: 2007-01-01
- Medicare Coverage Status: Carrier Judgement
- BETOS Classification: Oncology - other
Medicare has not assigned a fee schedule for this code
G9131
G9133 